Clinical effect analysis of one-stage in situ implantation combined with VSD in the treatment of limb skin degloving injury
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
万方数据
目的:探讨分析一期原位回植联合负压封闭引流技术(VSD)和红光治疗四肢皮肤脱套伤的临床疗效,为提高临床治疗四肢皮肤脱套伤效果提供可靠依据.方法:收集四肢皮肤脱套伤患者65例,研究组35例行一期原位回植联合VSD和红光治疗,对照组30例行一期原位回植后加压包扎,观察对比两组回植皮肤优良率、术后创面感染率及视觉模拟评分法(VAS)疼痛评分等指标,评估治疗效果.结果:术后随访 6～12个月,平均随访(8.91±1.95)个月,研究组35例患者回植皮肤成活效果为优30例、良者3例、差者2例,总体优良率94.29%,对照组30例患者回植皮肤成活效果为优 20例、良者 4例、差者 6例,总体优良率 80.00%;研究组术后创面感染 4例,感染率11.43%,对照组术后创面感染6例,感染率20.00%;研究组术后24 h VAS疼痛评分为(2.11±0.80)分,术后1周为(1.63±0.65)分,对照组术后24 h VAS疼痛评分为(3.03±0.93)分,术后1周为(2.40±0.67)分,差异均有统计学意义(均P<0.05).结论:四肢皮肤脱套伤行一期原位回植联合VSD和红光治疗,回植皮肤成活率高,四肢功能恢复佳,感染率低,VAS疼痛评分低,具有很高的临床应用价值.
Objective:To investigate the clinical efficacy of one-stage in situ sealing drainage combined with vacuum sealing drainage(VSD)and red light therapy for treating limb skin degloving injuries,aiming to establish a reliable foundation for enhancing clinical treatment protocols.Methods:A total of 65 pa-tients with skin degloving injury of limbs were collected.35 patients in the study group received one-stage in situ implantation combined with VSD and red light treatment,and 30 patients in the con-trol group received pressure dressing after one-stage in situ implantation.The excellent and good rate of skin implantation,postoperative wound infection rate,and visual analogue scale(VAS)pain score of the two groups were observed and compared to evaluate the therapeutic effect.Results:The average follow-up was(8.91±1.95)months for 6 to 12 months.In the study group,the survival ef-fect of skin replantation was excellent in 30 cases,good in 3 cases,and poor in 2 cases,with an overall excellent and good rate of 94.29%.In the control group,the survival effect of skin replantation was excellent in 20 cases,good in 4 cases,and poor in 6 cases.Overall good rate was 80.00%.There were 4 postoperative wound infections(11.43%)in the study group and 6 postoperative wound infec-tions(20.00%)in the control group.The VAS pain score of the study group was(2.11±0.80)points 24 hours after surgery and(1.63±0.65)points 1 week after surgery,and that of the control group was(3.03±0.93)points 24 hours after surgery and(2.40±0.67)points 1 week after surgery,with statisti-cal significance(all P<0.05).Conclusion:One-stage in situ reimplantation combined with VSD and red light treatment for limb skin degloving injury can achieve a high survival rate,good limb function recovery,low infection rate,and low VAS pain score,which has high clinical application value.
NETL
NSTL
万方数据
